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It is now well accepted that signal transduction depends on the
speciﬁc, regulated binding of proteins to other proteins and to
other cellular structures such as membrane lipids. From the pio-
neering work of Tony Pawson and others, we know that such inter-
actions are often mediated by modular protein domains [1,2]. With
the availability of complete genome sequences and the advent of
high-throughput methods to analyze protein interactions, this
insight has led to a wealth of information on various signaling
pathways. From ‘‘hairball’’ network diagrams to detailed pathway
cartoons, it would seem that we have more than enough informa-
tion to understand both the general design principles and speciﬁc
mechanistic details of most signaling pathways. Despite this
progress, however, the dynamic behavior of individual signaling
complexes remains something of a mystery. In this brief perspec-
tive, I will focus on emerging ideas on the dynamics of one of the
most intensively studied classes of signal transduction complexes,
those involving receptor tyrosine kinases (RTKs).
Binding of speciﬁc ligands to RTKs leads to increased activity of
their cytosolic tyrosine kinase catalytic domains [3]. Similarly,
non-receptor tyrosine kinases can be activated by ligand binding
to transmembrane receptors lacking intrinsic kinase activity, such
as cytokine and T cell receptors and integrins. For downstream sig-
naling, the most critical substrates of the activated kinases arechemical Societies. Published by Egenerally the receptor itself, along with receptor-associated scaf-
fold proteins. This is because the resulting phosphorylation sites
serve to recruit effector and adaptor proteins that contain phos-
photyrosine (pTyr) speciﬁc binding domains, predominantly Src
homology 2 (SH2) domains [4,5]. The net result is the relocaliza-
tion of a set of effector proteins to the receptor on the membrane,
and the assembly of multi-component signaling complexes that set
in motion downstream signaling cascades.
This mechanism is but one example of the many signaling sys-
tems that follow the ‘‘reader-writer-eraser’’ paradigm [6,7]. In
these systems, signal output depends on post-translational marks
laid down by writer enzymes; these marks can be removed by era-
ser enzymes, and are read by proteins that bind speciﬁcally to the
marked sites. In the case of tyrosine kinase signaling, the writers
are protein tyrosine kinases, the erasers are protein–tyrosine phos-
phatases, and the readers are modular pTyr binding domains such
as SH2 and PTB domains [6] (Fig. 1a).
Let’s consider the RTK system a bit more closely. Downstream
signaling (signal output) depends on the amount of effectors
recruited to the activated receptor and the identity of those
effectors. What then actually controls output levels at any point
in time? Of course the rate of tyrosine phosphorylation is
important, but so too is the rate of dephosphorylation, as well as
the concentration and afﬁnity of effectors (since the levels of a
bimolecular complex depend on the concentrations of the two
partners and the dissociation constant, Kd, of the interaction)
(Fig. 1b). Typically, descriptions of RTK signaling focus on kinase
activity, because this is what is known to change upon ligandlsevier B.V. All rights reserved.
ab
Fig. 1. Regulation of signal output from receptor tyrosine kinases. (a) Signaling is
controlled by the activities of tyrosine kinases, tyrosine phosphatases, and effector
proteins that can bind to tyrosine-phosphorylated sites. (b) The amount of signal
output is proportional to the amount of effector complexes, which in turn depends
on the rates of phosphorylation and dephosphorylation, and the local concentration
and afﬁnities of effectors.
Fig. 2. Constitutive rate of tyrosine dephosphorylation in cells is high. Human 293T
cells were treated with 50 micromolar pervanadate for the indicated times to
inhibit cellular tyrosine phosphatases. Cell lysates were then immunoblotted with
anti-phosphotyrosine antibody (pTyr). Levels of tyrosine phosphorylation rise
rapidly in pervanadate-treated cells. Lysates were also immunoblotted with anti-
actin as a loading control (bottom). Positions of molecular weight markers are
indicated on left (in kDa).
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are usually considered to be relatively constant, at least over the
rather short time scales relevant to signaling). I will argue, how-
ever, that the actual dynamic behavior of such complexes can be
understood fully only when all three factors are considered.
2. Cellular phosphatase activities are high
There is evidence that the activity of endogenous tyrosine phos-
phatases is surprisingly high. Anyone who has ever treated cells in
culture with the potent tyrosine phosphatase inhibitor vanadate
has seen that tyrosine phosphorylation levels increase enormously,
suggesting that phosphatase activity normally holds the steady-
state level of pTyr in check [8]. These effects are also quite rapid
(Fig. 2), suggesting that kinases must continuously ﬁght against a
strong and steady headwind of phosphatase activity. The same
conclusion can be drawn from recent studies looking at the rate
of dephosphorylation of an RTK, the epidermal growth factor
receptor (EGFR), upon treatment of cells with EGFR-speciﬁc kinase
inhibitors [9]. In these experiments the half-life of phosphorylation
on receptors was found to be very short, 15 s. The implication of
both types of studies is that steady-state rates of phosphorylation
and dephosphorylation are both very high, and that sites may be
phosphorylated and then dephosphorylated within a matter of
seconds.
Conceptually, this insight fundamentally alters how we view
changes in tyrosine phosphorylation upon RTK activation.Currently, we tend to think that little is going on in unstimulated
cells, and that ligand stimulation dramatically changes the situa-
tion by introducing an activated kinase into this quiet scene. In-
stead, it seems there is considerable ﬂux through the system
even in the unstimulated cell: a constant battle between spontane-
ously activated kinases and the phosphatases that remove their
marks. Intuitively this makes little sense, because each round of
phosphorylation and dephosphorylation costs an ATP molecule;
high ﬂux in the absence of speciﬁc signals would seem to be enor-
mously wasteful. Of course, we are willing to accept other seem-
ingly wasteful processes, such as the transcription of lengthy
introns in most eukaryotic genes, so such apparent proﬂigacy
cannot be a disqualifying feature in biological systems.
Presumably, however, there must be advantages to high ﬂux
that more than make up for the waste of energy. What might these
advantages be? A number of plausible scenarios can be proposed.
For example, high ﬂux is likely to make the system more depen-
dent on dimerization and higher-order clustering, presumably
helping eliminate background ‘‘noise’’ from spontaneously acti-
vated kinases. In the presence of high constitutive phosphatase
levels, a kinase that spontaneously adopts an activated conforma-
tion in the absence of ligand would be rapidly dephosphorylated,
as would any other substrates it might phosphorylate during its
brief period of activity. Genuine ligand-induced signals, on the
other hand, induce or stabilize receptor dimerization and often
lead to higher-order clustering [3]. Furthermore, the active confor-
mation of the catalytic domain is generally stabilized by phosphor-
ylation in trans on the ‘‘activation loop’’ [10]. The proximity of
multiple kinase molecules allows each activated kinase to repeat-
edly phosphorylate and trans-activate other kinases, and also
repeatedly phosphorylate substrates in the immediate vicinity.
Any kinase that happens to be dephosphorylated can be rapidly
re-phosphorylated by other nearby kinases. Thus the equilibrium
shifts dramatically from dephosphorylation to phosphorylation in
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phorylation, spontaneous activity would likely lead to much higher
basal (unstimulated) levels of substrate phosphorylation.
High phosphatase activity may also present advantages in
terms of protein engineering. The protein tyrosine kinases evolved
relatively recently, around the time when metazoans emerged
[6,11,12], and may not have had the evolutionary time to ‘‘perfect’’
themselves, in contrast to more ancient enzymes such as those in-
volved in metabolism. High constitutive phosphatase activity may
allow tyrosine kinases to function in signaling despite imperfect
control over their activity and substrate speciﬁcity. First, if
constitutive phosphatase activity is high, a fairly high level of leaky
activity can be tolerated; that is, the difference in average catalytic
activity between unliganded and liganded RTKs can be modest. As
outlined above, spontaneous activity (in absence of speciﬁc ligand)
is unlikely to have serious consequences if the kinase is not clus-
tered with other kinases. Second, substrate speciﬁcity is not abso-
lutely crucial, since any ‘‘mistakes’’—proteins phosphorylated on
sites that are not useful or may even be deleterious—are quickly
erased by phosphatases. Of course, this raises the question of
how tyrosine-phosphorylated sites important for signaling can
selectively survive the high phosphatase activity—the subject of
the next section.Fig. 3. The Whac-a-Mole game (used with permission of Bob’s Space Racers, Inc.).3. Effectors actively edit the cellular pTyr proﬁle
When phosphatase rates are high in cells, the half-life of phos-
phorylated sites must be relatively short. It follows from this that
proteins that bind particular phosphorylated sites are likely to af-
fect their levels, by shielding them from phosphatases and thus
delaying their dephosphorylation. While it has long been specu-
lated that this might be the case, there has been remarkably little
direct experimentation to conﬁrm it. It has been shown, not sur-
prisingly, that SH2 binding protects phosphorylated binding sites
from dephosphorylation in vitro [13]. The oncogenic Crk SH2/SH3
adaptor protein, which when highly expressed leads to increased
steady-state levels of its SH2 binding partners such as p130Cas
and paxillin, also supports this idea [14,15]; however since Crk also
binds to tyrosine kinases, a role for those kinases in increased pTyr
cannot be ruled out [16–18]. Consistent with expectations, more
recent experiments in my group have conﬁrmed that overexpres-
sion of an SH2 domain such as that of Grb2 can dramatically in-
crease the amount of phosphorylation of SH2-binding sites in
cells both before and after stimulation by EGF (J. Jadwin, K. Mach-
ida and BJM, unpublished observations).
Thus is seems that effectors are not just passive readers of the
post-translational marks laid down by tyrosine kinases, but actu-
ally play a much more active role in determining which sites will
predominate. By the very act of reading the signal, effectors pre-
vent the sites being read from being erased. Which readers are
present (and more quantitatively, their local concentrations and
on- and off-rates) determines not only the ultimate output of the
signal, but also the pattern of phosphorylation that is observed.
When dephosphorylation rates are high, effector recruitment
(and ultimately signal output) becomes a race between the rate
of dephosphorylation and the rate of effector binding, which in
turn is dependent on the local concentration of those effectors.
The popular arcade game ‘‘Whac-a-Mole’’ provides an apt analogy
(Fig. 3). In this game, mechanical moles periodically pop up from
one of a number of holes, then almost immediately pop back down.
In order to score points, the player needs to whack the mole with a
padded mallet before it disappears. The more moles whacked, the
higher the score. Similarly, SH2-containing effectors in the cytosol
must recognize and bind to tyrosine-phosphorylated receptors be-
fore they are dephosphorylated. The strength of the signal output(the score) depends on the number of sites that can be bound
per unit time.
4. Ptyr–effector complexes are highly transient
SH2 domains and other pTyr binding modules have moderate
afﬁnity and speciﬁcity; typical Kd’s for preferred phosphopeptides
are in the 100 nM range. Furthermore, when on-rates and off-
rates have been examined, for example by surface plasmon reso-
nance (SPR), the off-rates have been found to be remarkably rapid.
In the case of Grb2 SH2 domain examined by SPR, the off-rate is so
fast as to be unmeasurable, and could only be estimated from the
Kd and on-rate to be >10 s1 [19,20]. In other words, the average
half-life of an SH2–pTyr peptide complex in vitro is less than
100 ms. Thus clearly, if all of the binding energy of RTK-effector
binding were provided by the SH2–pTyr interaction, then these sig-
naling complexes must be extremely short-lived. The highly tran-
sient nature of such complexes has been conﬁrmed by single
molecule imaging, both in membrane preparations of EGF-treated
cells [21] and in live EGF-treated cells (Oh DM, Ogiue-Ikeda
M, Jadwin JA, Machida M, Mayer BJ, Yu J, manuscript submitted).
In vivo experiments done by Ji Yu’s group in collaboration with
my own have also revealed a number of other interesting proper-
ties of SH2–RTK complexes, all of which are consistent with a mod-
el in which each SH2 domain ‘‘hops’’ from site to site multiple
times before ﬁnally escaping the membrane into solution (Oh
et al., manuscript submitted) (Fig. 4). Such hopping is consistent
with theoretical work suggesting that a high local concentration
of binding sites on a surface, coupled with a high on-rate for asso-
ciation of a ligand, can generate slower apparent off-rates due to
repeated rebinding to the surface [22–24]. In the case of individual
SH2 domains examined in vivo by single-molecule imaging, even
with repeated rebinding the apparent off-rate for SH2 domains is
quite fast, with half-times of a second or two.
Fig. 4. Surface rebinding affects apparent off-rates. Binding is illustrated for an SH2 domain to phosphorylated sites (red circles) on an RTK on the membrane. For simple
chemical kinetics, the amount of binding of the SH2 domain is determined by the on-rate and off-rate for the bimolecular interaction (left). If density of binding sites and on-
rate are high, however, the domain may ‘‘hop’’ from site to site on the membrane (dotted arrows) before ﬁnally escaping. The dwell-time on the membrane is much longer
than predicted by the simple off-rate.
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domain may behave very differently from full-length effector or
adaptor proteins, all of which contain other interaction domains
that could work cooperatively to assemble larger and more sta-
ble signaling complexes. Recent data have demonstrated second-
ary interactions beyond the pTyr–SH2 interface providing
additional afﬁnity and speciﬁcity to interactions [25], and
cooperative binding is a ubiquitous and under-appreciated as-
pect of biological signaling mechanisms [26]. In the speciﬁc case
of Grb2, in vitro studies showed that full-length Grb2,
complexed with its primary effector Sos, had a somewhat higher
afﬁnity for pTyr peptides than the SH2 domain alone [19]. Con-
sistent with this, in vivo single molecule imaging experiments
showed that binding of full-length Grb2 was moderately more
stable than the SH2 alone, but still was highly transient and
was dominated by the SH2 interaction; no evidence of
cooperative interactions via other binding proteins was found
(Oh et al., manuscript submitted).
The apparent transience of SH2–pTyr interactions in vivo
raises an interesting technical question: why do the workhorse
methods for detecting protein interactions, co-immunoprecipita-
tion and pulldown assays, work at all? Such methods absolutely
depend on relatively stable protein interactions lasting many
minutes. If the actual half-time of SH2-mediated associations is
on the order of seconds, then binding partners should be lost al-
most immediately in the washing steps. Of course, the relatively
high density of an antibody or fusion protein on a bead might
suppress escape from the surface in the same way that is seen
in vivo; however protein densities on beads are unlikely to be
signiﬁcantly higher than those seen in living cells, where binding
appears to be highly transient. Another possibility is that cooper-
ative, multivalent, multi-protein complexes are assembled on
beads, but again it is curious that this should happen in cell ly-
sates but not in living cells. We also need to consider possible
experimental artifacts, such as non-physiological disulﬁde bond
formation, or irreversible denaturation or precipitation of pro-
teins onto the surface of beads.
What are some of the implications if the hopping mechanism
proves to be an accurate representation of RTK signaling com-
plexes? First, such a mechanism would make signaling even more
dependent on the local density of pTyr sites. The number of hops
an SH2-containing effector makes before it can escape depends
on the density of binding sites, so membrane regions with higher
pTyr density will promote longer average dwell-times on the
membrane for their binding partners. Indeed, in single-molecule
experiments the dwell-time of Grb2 SH2 domain increased sub-
stantially with increasing time after EGF stimulation, correlatingwith increased clustering of activated receptors (Oh et al., manu-
script submitted).
In terms of the bigger picture, a hopping mechanism provokes
us think more carefully about what we actually mean when we
say that effectors are ‘‘recruited’’ to the phosphorylated receptor
on the membrane. The static cartoon is easy to understand: effec-
tors are afﬁxed to the membrane-bound receptor, so they have
ready access to their substrates (lipids, membrane-associated pro-
teins). But what does it mean if the effector is hopping from site to
site, spending much of its time in solution ‘‘in ﬂight’’ between dif-
ferent binding sites? Perhaps what is most important is increasing
the likelihood of collision of effectors with their substrates on the
membrane [27,28].
Finally, such a mechanism might lessen the importance for
downstream signaling of individual high-afﬁnity sites for a partic-
ular effector. The Grb2 single-molecule data are consistent with
each SH2 domain transiently binding to 20 different sites before
ﬁnally escaping from the membrane (Oh et al., manuscript submit-
ted). Most RTKs lead to phosphorylation of many different sites
upon activation. When an effector samples multiple sites with
varying afﬁnities during one encounter with the membrane, these
different afﬁnities are effectively averaged together. Loss of a par-
ticularly high afﬁnity site will lower the average dwell-time to
some extent, but is unlikely to make a binary (binds/does not bind)
difference. This averaging effect due to hopping might help explain
some earlier studies in which individual RTK phosphorylation sites
were mutated. Contrary to expectation, in many cases loss of the
preferred binding site for a particular SH2-containing effector
had little effect on downstream signaling. It was only in a back-
ground where all major phosphorylation sites were eliminated
and single high-afﬁnity sites were added back that signiﬁcant
effects could be seen [29,30].
A more practical effect of binding site hopping might be to sim-
plify the quantitative modeling of RTK signaling. Because each RTK
has many different possible phosphorylation sites, and because
receptors dimerize upon activation, the number of possible dis-
crete phosphorylated receptor species can become enormous. This
combinatorial explosion of sites is a major potential problem for
quantitative modeling, because in principle each different species
must be explicitly accounted for in any mathematical model
[31,32]. Most current models get around this problem by making
simplifying assumptions, such as deﬁning the receptor as existing
in only two states, unphosphorylated or phosphorylated. If binding
of effectors to the receptor is not really a discrete event, but instead
is averaged over many different transient interactions, then such
simpliﬁcations are much more likely to be valid representation of
actual signaling behavior.
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In this speculative look at the dynamic behavior of RTK signal-
ing complexes, I have argued that the constitutive tyrosine phos-
phatase activity in cells is quite high, and that this has signiﬁcant
implications for downstream signaling. It allows tyrosine kinases
to be rather sloppy enzymes, and it makes signal output highly
dependent on receptor clustering. Furthermore, it insures that
pTyr-binding effectors play an active role in determining the phos-
phorylation pattern in cells. I also argue that effector binding is rel-
atively transient in vivo, and may involve sampling multiple
binding sites during each membrane encounter. What emerges is
a highly dynamic motion picture of RTK signaling, one that is quite
different from static textbook cartoons of receptors in their inac-
tive and active states.
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